Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2021 Jun 14;35(7):e23820. doi: 10.1002/jcla.23820

A dynamic nomogram for predicting the risk of asthma: Development and validation in a database study

Lifen Yang 1,2, Meihua Li 1,2, Qinling Zheng 1,2, Chaofeng Ren 1,2, Wei Ma 1,2, Yanxia Yang 1,2,
PMCID: PMC8275008  PMID: 34125979

Abstract

Background

Asthma remains a serious health problem with increasing prevalence and incidence. This study was to develop and validate a dynamic nomogram for predicting asthma risk.

Methods

Totally 597 subjects whose age ≥18 years old with asthma, an accurate age at first cigarette, and clear smoking status were selected from the National Health and Nutrition Examination Survey (NHANES) database (2013–2018). The dataset was randomly split into the training set and the testing set at a ratio of 4:6. Simple and multiple logistic regressions were used for identifying independent predictors. Then the nomogram was developed and internally validated using data from the testing set. The receiver operator characteristic (ROC) curve was used for assessing the performance of the nomogram.

Results

According to the simple and multiple logistic regressions, smoking ≥40 years, female gender, the age for the first smoking, having close relative with asthma were independently associated with the risk of an asthma attack. The nomogram was thereby developed with the link of https://yanglifen.shinyapps.io/Dynamic_Nomogram_for_Asthma/. The ROC analyses showed an AUC of 0.726 (0.724–0.728) with a sensitivity of 0.887 (0.847–0.928) in the training set, and an AUC of 0.702 (0.700–0.703) with a sensitivity of 0.860 (0.804–0.916) in the testing set, fitting well in calibration curves. Decision curve analysis further confirmed the clinical usefulness of the nomogram.

Conclusion

Our dynamic nomogram could help clinicians to assess the individual probability of asthma attack, which was helpful for improving the treatment and prognosis of asthma.

Keywords: asthma, dynamic nomogram, NHANES database, smoking duration


We developed and internally validated a dynamic nomogram to help clinicians to estimate the individual probability of asthma, which was useful for improving the treatment and prognosis of asthma.

graphic file with name JCLA-35-e23820-g006.jpg

1. INTRODUCTION

Asthma is a chronic disease principally characterized by episodic wheeze, cough, and breathlessness resulting from airway hyperresponsiveness and inflammation, and it has affected 358 million people in the world. 1 It is estimated that the number of asthmatics would increase by an additional 100 million in 2025. 2 Many environmental influencing factors, including tobacco smoking, air pollution, occupations, and diet, have been identified for the onset and development of asthma. 3

Among them, tobacco smoking has been reported to induce neutrophilic airway inflammation and airway remodeling, thereby accelerating airway obstruction and the decline of lung function, which can contribute to the onset and development of asthma. 4 , 5 , 6 Many studies have demonstrated the cause‐effect relationship between smoking and asthma, suggesting that smoking results in poorer asthma control and more severe asthma exacerbations. 7 , 8 , 9 Asthmatics were more likely to be regular and heavier smokers than those without asthma. 10 And continuous smokers were more likely to develop asthma, 11 which could be interpreted as the accelerated loss of lung function over time in adult‐onset asthma. 12 However, there still exists inconsistency. Eisner et al suggested that patients with asthma had a shorter duration of smoking as compared with smokers in the general population, and no significant difference was found in the duration of smoking. 13

Currently, a nomogram is a useful tool for estimating the prognosis in oncology and medicine. It can simplify the traditional formulas of the prediction model into an estimated number of the probability of a single endpoint event. 14 , 15 Based on the static nomogram, the dynamic nomogram is to generate an online scoring system, where the user‐friendly interface is more convenient for clinicians to tailor clinical decisions for an individual patient. To our knowledge, a dynamic nomogram has not yet been established for predicting the probability of asthma development. Herein, this study was to investigate the predictors of the asthma attack, especially the correlation between the duration of smoking and asthma using the National Health and Nutrition Examination Survey (NHANES) database. Further, we aimed to develop and validate a dynamic nomogram for predicting asthma attacks.

2. MATERIAL AND METHODS

2.1. Study population

In this study, subjects from the NHANES database (2013–2018) were collected. Inclusion criteria: (1) age ≥18 years old; (2) with a confirmed diagnosis of asthma; (3) with an accurate age at first cigarette; (4) with clear smoking status: smokers or non‐smokers.

2.2. Data collection

Baseline variables including age, gender, race, body mass index (BMI), presence or absence of asthma, age at the first cigarette, the frequency of smoking, age when first had asthma, whether having close relative with asthma, years of smoking, whether having trouble in sleeping, were extracted for analysis (See File S1).

National Health and Nutrition Examination Survey is a program of studies designed to assess the health and nutritional status of adults and children in the United States, which combines interviews and physical examinations (https://www.cdc.gov/nchs/nhanes/index.htm). The sample for the NHANES survey is selected to represent the United States population of all ages. 16 NHANES is an open database, so the Institutional Review Board approval or informed consent by subjects are not required for this study.

2.3. Statistical analysis

The dataset was randomly split into the training set and the testing set at a ratio of 4:6. Simple and multiple logistic regressions were used for identifying independent predictors of asthma. Then the nomogram was developed and internally validated using data from the testing set. The receiver operator characteristic (ROC) curve was used for assessing the performance of the nomogram, and the ShinyApp (RStudio, PBC) was used for making the online nomogram.

Quantitative variables were expressed as mean ± standard deviation (Mean ± SD) or median and quartile (M [Q1, Q3]), and t test or Wilcoxon rank‐sum test was used for comparison between groups. Qualitative variables were expressed as number and percentage (n [%]), and χ 2 test or Fisher's exact test was used for comparison. Statistical analysis was performed using SPSS 26.0 software (IBM Corp., Armonk, NY, USA), and p < 0.05 was considered statistically significant.

3. RESULTS

3.1. Baseline clinical characteristics

In the present study, 597 eligible subjects including 288 males (48.24%) and 309 females (51.76%) were enrolled and divided into the training set (n = 358) and the testing set (n = 239). The median age at screening was 42.00 (30.00, 57.00) years, and the median age at the first cigarette was 16.00 (14.00, 19.00) years. The 460 subjects (77.05%) reported smoking daily, 116 (19.43%) smoking regularly, and 21 (3.52%) never smoking. The 288 subjects (48.24%) reported asthma in their close relatives, and 283 (47.40%) reported no asthma in relatives. The median age for the first asthma attack was 12.00 (6.00, 30.00) years. The 381 subjects (63.82%) had asthma, and 216 (36.18%) had no asthma or had no recurrence of asthma. The details of the baseline characteristics were shown in Table 1. According to the results, there were no significant differences in all characteristics between the training set and the testing set (all p > 0.05).

TABLE 1.

Baseline clinical characteristics of subjects

Variables, n (%)

Total

(n = 597)

Testing set

(n = 239)

Training set

(n = 358)

Statistics p
Asthma
No 216 (36.18) 89 (37.24) 127 (35.47) χ 2 = 0.124 0.724
Yes 3 150 (62.76) 231 (64.53)
Gender
Male 288 (48.24) 109 (45.61) 179 (50.00) χ 2 = 0.939 0.333
Female 309 (51.76) 130 (54.39) 179 (50.00)
Age, M (Q1, Q3), years 42.00 (30.00, 57.00) 42.00 (30.50, 57.00) 43.00 (30.00, 56.00) Z = 0.336 0.737
Race
Mexican American 43 (7.20) 16 (6.69) 27 (7.54) χ 2 = 4.046 0.543
Other Hispanic 46 (7.71) 18 (7.53) 28 (7.82)
Non‐Hispanic white 286 (47.91) 106 (44.35) 180 (50.28)
Non‐Hispanic black 163 (27.30) 70 (29.29) 93 (25.98)
Non‐Hispanic Asian 20 (3.35) 9 (3.77) 11 (3.07)
Other 39 (6.53) 20 (8.37) 19 (5.31)
BMI, kg/m2
Underweight/normal 166 (27.81) 62 (25.94) 104 (29.05) χ 2 = 0.544 0.461
Overweight 431 (72.19) 177 (74.06) 254 (70.95)
Age at first cigarette, M (Q1, Q3), years 16.00 (14.00, 19.00) 16.00 (14.00, 19.00) 16.00 (14.00, 18.00) Z = −0.491 0.623
Frequency of smoking
Daily 460 (77.05) 184 (76.99) 276 (77.09) χ 2 = 0.044 0.978
Sometimes 116 (19.43) 47 (19.67) 69 (19.27)
Never 21 (3.52) 8 (3.35) 13 (3.63)
Age for first asthma attack, M (Q1, Q3), years 12.00 (6.00, 30.00) 12.00 (5.00, 32.50) 14.00 (6.00, 30.00) Z = −0.609 0.543
Close relative has asthma
Yes 288 (48.24) 120 (50.21) 168 (46.93) χ 2 = 0.798 0.671
No 283 (47.40) 110 (46.03) 173 (48.32)
Unknown 26 (4.36) 9 (3.77) 17 (4.75)
Duration of smoking
Not 24 (4.02) 9 (3.77) 15 (4.19) χ 2 = 3.006 0.699
1–10 116 (19.43) 50 (20.92) 66 (18.44)
10+ 118 (19.77) 49 (20.50) 69 (19.27)
20+ 100 (16.75) 38 (15.90) 62 (17.32)
30+ 96 (16.08) 32 (13.39) 64 (17.88)
40+ 143 (23.95) 61 (25.52) 82 (22.91)
Trouble in sleeping
No 279 (46.73) 100 (41.84) 179 (50.00) χ 2 = 3.512 0.061
Yes 318 (53.27) 139 (58.16) 179 (50.00)

Abbreviation: BMI, body mass index.

3.2. Simple and multiple logistic regression

The training set was divided into the asthma group (n = 231) and the non‐asthma group (n = 127). All baseline characteristics in the training set were included in the univariate analysis, and the results showed that significant differences were found in gender (p = 0.002), age (p = 0.009), the age for the first asthma attack (p < 0.001), whether having close relative with asthma (p = 0.005) and years of smoking (p = 0.023) between the two groups (Table 2).

TABLE 2.

Univariate analysis of the training set

Variables, n (%)

Total

(n = 358)

Non‐asthma group

(n = 127)

Asthma group

(n = 231)

Statistics p
Gender
Male 179 (50.00) 78 (61.42) 101 (43.72) χ 2 = 9.567 0.002
Female 179 (50.00) 49 (38.58) 130 (56.28)
Age, M (Q1, Q3), years 43.00 (30.00, 56.00) 37.00 (28.00, 53.50) 47.00 (32.00, 58.00) Z = −2.614 0.009
Race
Mexican American 27 (7.54) 12 (9.45) 15 (6.49) Fisher 0.307
Other Hispanic 28 (7.82) 11 (8.66) 17 (7.36)
Non‐Hispanic white 180 (50.28) 62 (48.82) 118 (51.08)
Non‐Hispanic black 93 (25.98) 30 (23.62) 63 (27.27)
Non‐Hispanic Asian 11 (3.07) 7 (5.51) 4 (1.73)
Other 19 (5.31) 5 (3.94) 14 (6.06)
BMI, kg/m2
Underweight/normal 104 (29.05) 47 (37.01) 57 (24.68) χ 2 = 5.463 0.019
Overweight 254 (70.95) 80 (62.99) 174 (75.32)
Frequency of smoking
Daily 276 (77.09) 92 (72.44) 184 (79.65) Fisher 0.257
Sometimes 69 (19.27) 29 (22.83) 40 (17.32)
Never 13 (3.63) 6 (4.72) 7 (3.03)
Age for first asthma attack, M (Q1, Q3), years 14.00 (6.00, 30.00) 9.00 (5.00, 16.00) 18.00 (7.00, 35.00) Z = −4.612 <0.001
Close relative has asthma
Yes 168 (46.93) 46 (36.22) 122 (52.81) χ 2 = 10.485 0.005
No 173 (48.32) 76 (59.84) 97 (41.99)
Unknown 17 (4.75) 5 (3.94) 12 (5.19)
Duration of smoking
Not 15 (4.19) 8 (6.30) 7 (3.03) χ 2 = 13.092 0.023
1–10 66 (18.44) 29 (22.83) 37 (16.02)
10+ 69 (19.27) 30 (23.62) 39 (16.88)
20+ 62 (17.32) 23 (18.11) 39 (16.88)
30+ 64 (17.88) 18 (14.17) 46 (19.91)
40+ 82 (22.91) 19 (14.96) 63 (27.27)

Abbreviation: BMI, body mass index.

In this analysis, the significant characteristics in the univariate analysis were included in the multiple logistic regression. After gender and age were adjusted, we found that smoking ≥40 years, female gender, the age for the first smoking, having close relative with asthma were independently associated with the risk of the asthma attack. The risk was 3.448‐fold (95% CI: 1.213–16.538) higher in subjects with ≥40 years of smoking compared to non‐smokers. And the risk was 1.382‐fold (95% CI: 1.461–3.925) higher in subjects having close relative with asthma compared to those without (Figure 1).

FIGURE 1.

FIGURE 1

Multiple logistic regression of the training set

In addition, the restricted cubic splines (RCS) were used to flexibly model and visualize the relations between smoking duration and asthma risk, and between age for the first asthma attack and asthma risk. The results showed that there were no nonlinear associations between smoking duration and asthma risk (p = 0.657) (Figure 2), nor between age for the first asthma attack and asthma risk (p = 0.569) (Figure 3).

FIGURE 2.

FIGURE 2

RCS for smoking duration and asthma risk

FIGURE 3.

FIGURE 3

RCS for age for first asthma attack and asthma risk

3.3. Development and validation of the nomogram

According to the results of the multiple logistic regression, predictors including gender, years of smoking, the age for the first asthma attack, and whether having close relative with asthma as well as age were identified and the nomogram was thereby developed with the link of https://yanglifen.shinyapps.io/Dynamic_Nomogram_for_Asthma/ (Figure 4). The results of the ROC analyses showed an AUC of 0.726 (0.724–0.728) with a sensitivity of 0.887 (0.847–0.928) in the training set, and an AUC of 0.702 (0.700–0.703) with a sensitivity of 0.860 (0.804–0.916) in the testing set, suggesting the good performance of our nomogram (Figure 5). As shown in Figure 6, the net benefit of the decision curve for the nomogram is higher with a higher threshold, suggesting that our nomogram could improve the clinical outcome. Also, the calibration curve showed that the predicted probability of the nomogram was closely aligned with the actual estimates (p = 0.226) (Figure 7), confirming the goodness‐of‐fit of the model.

FIGURE 4.

FIGURE 4

ROC curves of the training set and the testing set

FIGURE 5.

FIGURE 5

Interface of the dynamic nomogram

FIGURE 6.

FIGURE 6

Decision curve for the nomogram

FIGURE 7.

FIGURE 7

Calibration curve for the nomogram

4. DISCUSSION

In recent decades, asthma remains as a serious health problem with increasing prevalence and incidence. Identifying high‐risk population who may suffer from asthma attacks is necessary to improve the treatment and outcome of the disease. In this population‐based study, we developed and validated an online nomogram for predicting the individual probability of asthma attack (link: https://yanglifen.shinyapps.io/Dynamic_Nomogram_for_Asthma/). The ROC analysis for the training set showed an AUC of 0.726. After internal validation, the AUC of the testing set was 0.702, which reveals the good predictive performance of our model.

Smoking ≥40 years, female gender, having close relative with asthma, and age for the first asthma attack were identified as independent predictors for asthma. It is well‐recognized that tobacco smoking can lead to inflammatory changes in the airway tract and result in the development of persistent wheezing and worsening of respiratory symptoms. 17 , 18 Long‐term smoking can accelerate the loss of lung function and finally cause the onset of asthma. 12 Our findings suggested a 3.448‐fold higher risk of asthma in subjects with ≥40 years of smoking compared to non‐smokers. A population‐based Korean study reported similar findings that the years of smoking is likely to play a role in asthma manifestation. 4 The long duration of smoking may lead to the vulnerability of developing lung to harmful stimuli, which accelerates the asthma onset. However, Eisner et al demonstrated that no significant difference was found in the duration of smoking. 13 It was probably due to differences in the sample size and the smoking years of enrolled subjects between the two studies. Also, our results showed that females exhibited a 0.905‐fold higher risk of asthma compared to males, which may indicate gender difference in the asthma attack. Gender disparity has been reported to exist in asthma development. 19 , 20 , 21 , 22 , 23 , 24 Studies have found that women are more susceptible than men to respiratory diseases including asthma. 21 , 25 According to our results, subjects who have close relative with asthma showed a 1.382‐fold higher risk of asthma attack than those not, which could be hypothesized that family history may play a role in the asthma attack. A longitudinal study in Sweden noted the family history of asthma as an important risk factor for asthma development. 26 Young et al also demonstrated that the level of airway responsiveness was increased when there was a family history of asthma. 27

Although previous studies have developed several prediction models for the diagnosis of asthma, 28 , 29 , 30 , 31 , 32 we established an online nomogram which is more convenient for clinicians to evaluate the individual probability of asthma attack. Clinicians could access the website directly through their computer or phone, and input the information of patients to predict the risk of asthma attack, which would greatly facilitate the clinical use. And it enables to predict the patient's risk of asthma by evaluating simple factors such as demographic characteristics and medical history, without the need for complex examinations.

However, several limitations should also be considered. Firstly, the sample size in this study was relatively small, which requires a larger sample size for verification. Secondly, all data were extracted from NHANES, which is consisted of an in‐home interview and a health examination in the Mobile Examination Center (MEC). It may impose some limitations on the accuracy of our data, thus affecting the objectivity of the results. Thirdly, the established nomogram was internally validated, which requires different populations for external validation.

In our study, smoking ≥40 years, female gender, having close relative with asthma, and age for the first asthma attack were all correlated with asthma. We developed and internally validated a dynamic nomogram to help clinicians to estimate the individual probability of asthma, which was useful for improving the treatment and prognosis of asthma.

CONFLICT OF INTEREST

There is no conflict of interest in this work.

AUTHOR CONTRIBUTIONS

Lifen Yang and Yanxia Yang designed the study. Lifen Yang wrote the manuscript. Meihua Li, Qinling Zheng, Chaofeng Ren, and Wei Ma collected, analyzed, and interpreted the data. Yanxia Yang critically reviewed, edited, and approved the manuscript. All authors read and approved the final manuscript.

CONSENT FOR PUBLICATION

All the contributing authors agreed for the publication in this journal.

Supporting information

File S1

ACKNOWLEDGMENTS

None.

DATA AVAILABILITY STATEMENT

All the data released to this work are available at the corresponding author.

REFERENCES

  • 1. Collaborators GBDCRD . Global, regional, and national deaths, prevalence, disability‐adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691‐706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Croisant S. Epidemiology of asthma. Prevalence and burden of disease. Adv Exp Med Biol. 2014;795:17‐29. [DOI] [PubMed] [Google Scholar]
  • 3. National Asthma Education and Prevention Program TEPotDaMoA . Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute (US); 2007. [Google Scholar]
  • 4. Kim SY, Sim S, Choi HG. Active and passive smoking impacts on asthma with quantitative and temporal relations: A Korean Community Health Survey. Sci Rep. 2018;8(1):8614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Wu D, Lai T, Yuan Y, et al. Elevated expression of placental growth factor is associated with airway‐wall vascular remodelling and thickening in smokers with asthma. Sci Rep. 2017;7:43017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Chaudhuri R, McSharry C, Brady J, et al. Low sputum MMP‐9/TIMP ratio is associated with airway narrowing in smokers with asthma. Eur Respir J. 2014;44(4):895‐904. [DOI] [PubMed] [Google Scholar]
  • 7. McLeish AC, Cougle JR, Zvolensky MJ. Asthma and cigarette smoking in a representative sample of adults. J Health Psychol. 2011;16(4):643‐652. [DOI] [PubMed] [Google Scholar]
  • 8. McCoy K, Shade DM, Irvin CG, et al. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol. 2006;118(6):1226‐1233. [DOI] [PubMed] [Google Scholar]
  • 9. Schatz M, Zeiger RS, Vollmer WM, Mosen D, Cook EF. Determinants of future long‐term asthma control. J Allergy Clin Immunol. 2006;118(5):1048‐1053. [DOI] [PubMed] [Google Scholar]
  • 10. Avila LS‐MM, Soto‐Quiros ME, Celedon JC. Asthma, current wheezing, and tobacco use among adolescents and young adults in Costa Rica. J Asthma. 2005;43:543‐547. [DOI] [PubMed] [Google Scholar]
  • 11. Godtfredsen NS, Lange P, Prescott E, Osler M, Vestbo J. Changes in smoking habits and risk of asthma: a longitudinal population based study. Eur Respir J. 2001;18(3):549‐554. [DOI] [PubMed] [Google Scholar]
  • 12. Teague WG. Up in smoke: accelerated loss of lung function in two clusters of smokers identified in a longitudinal cohort study of adult‐onset asthma. J Allergy Clin Immunol Pract. 2017;5(4):979‐980. [DOI] [PubMed] [Google Scholar]
  • 13. Eisner MD, Yelin EH, Trupin L, Blanc PD. Asthma and smoking status in a population‐based study of California adults. Public Health Rep. 2001;116(2):148‐157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173‐e180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364‐1370. [DOI] [PubMed] [Google Scholar]
  • 16. Xu B, Lin J. Characteristics and risk factors of rheumatoid arthritis in the United States: an NHANES analysis. PeerJ. 2017;5:e4035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Copenhaver CC, Gern JE, Li Z, et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med. 2004;170(2):175‐180. [DOI] [PubMed] [Google Scholar]
  • 18. Burney P, Jarvis D, Perez‐Padilla R. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis. 2015;19(1):10‐20. [DOI] [PubMed] [Google Scholar]
  • 19. Pignataro FS, Bonini M, Forgione A, Melandri S, Usmani OS. Asthma and gender: the female lung. Pharmacol Res. 2017;119:384‐390. [DOI] [PubMed] [Google Scholar]
  • 20. Zein JG, Denson JL, Wechsler ME. Asthma over the adult life course: gender and hormonal influences. Clin Chest Med. 2019;40(1):149‐161. [DOI] [PubMed] [Google Scholar]
  • 21. Fuseini H, Newcomb DC. Mechanisms driving gender differences in asthma. Curr Allergy Asthma Rep. 2017;17(3):19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. McGuire S, Centers for Disease Control and Prevention . Vital signs: binge drinking among women and high school girls‐‐United States, 2011. Adv Nutr. 2013;4(3):313‐314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Moorman JE, Zahran H, Truman BI, Molla MT, Centers for Disease Control and Prevention . Current asthma prevalence ‐ United States, 2006‐2008. MMWR Suppl. 2011;60(1):84‐86. [PubMed] [Google Scholar]
  • 24. Syamlal G, Mazurek JM, Dube SR. Gender differences in smoking among U.S. working adults. Am J Prev Med. 2014;47(4):467‐475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Jarolimova J, Tagoni J, Stern TA. Obesity: its epidemiology, comorbidities, and management. Prim Care Companion CNS Disord. 2013;15(5):PCC.12f01475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Ronmark E, Lundback B, Jonsson E, Jonsson AC, Lindstrom M, Sandstrom T. Incidence of asthma in adults–report from the obstructive lung disease in Northern Sweden study. Allergy. 1997;52(11):1071‐1078. [DOI] [PubMed] [Google Scholar]
  • 27. Young S, Le Souef PN, Geelhoed GC, Stick SM, Turner KJ, Landau LI. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med. 1991;324(17):1168‐1173. [DOI] [PubMed] [Google Scholar]
  • 28. Deng X, Gebretsadik T, Jin M, et al. Development of a nomogram for identification of asthma among adults in epidemiologic studies. Ann Allergy Asthma Immunol. 2010;105(3):203‐210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Lim SY, Jo YJ, Chun EM. The correlation between the bronchial hyperresponsiveness to methacholine and asthma like symptoms by GINA questionnaires for the diagnosis of asthma. BMC Pulm Med. 2014;14:161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Metting EI, in 't Veen JC, Dekhuijzen PN, et al. Development of a diagnostic decision tree for obstructive pulmonary diseases based on real‐life data. ERJ Open Res. 2016;2(1):77‐2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Schneider A, Wagenpfeil G, Jörres RA, Wagenpfeil S. Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma. BMJ Open. 2015;5(11):e009676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Tomita K, Sano H, Chiba Y, et al. A scoring algorithm for predicting the presence of adult asthma: a prospective derivation study. Prim Care Respir J. 2013;22(1):51‐58. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

File S1

Data Availability Statement

All the data released to this work are available at the corresponding author.


Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES